AMENDED AND RESTATED ROYALTY AGREEMENTAmended and Restated Royalty Agreement • November 17th, 2011 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This AMENDED AND RESTATED ROYALTY AGREEMENT (this “Agreement”), dated November 14, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Horizon Santé TTNP SARL, a Luxembourg limited company (“Horizon” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).
AMENDED AND RESTATED ROYALTY AGREEMENTAmended and Restated Royalty Agreement • February 12th, 2016 • Growblox Sciences, Inc. • Crude petroleum & natural gas • Nevada
This Amended and Restated Royalty Agreement (this “Agreement”), dated and effective as of February 8, 2016 (the “Effective Date”), by and between GrowBlox Sciences, Inc. a Delaware corporation (“GBS Delaware”), GB Sciences Nevada LLC, a Nevada limited liability company (“GBS Nevada”), and Pacific Leaf Ventures, LP, a California limited partnership (“PACIFIC LEAF”), amends and restates in its entirety that certain Royalty Agreement dated May 12, 2015, by and between GBS Delaware and PACIFIC LEAF (the “Original Royalty Agreement”).
